First New York Securities’s Albireo Pharma Inc ALBO Stock Holding History

First New York Securities’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,041	Closed	-$453K	–	559
2014 Q3	$453K	Buy	+9,041	New	+$520K	0.32%	72
2014 Q2	–	Sell	-8,133	Closed	-$666K	–	380
2014 Q1	$666K	Sell	8,133 -15,760	-66%	-$1.43M	0.33%	76
2013 Q4	$1.64M	Buy	23,893 +15,726	+193%	+$1.15M	0.99%	26
2013 Q3	$772K	Buy	+8,167	New	+$1.06M	0.31%	70

Other funds holding ALBO

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

First New York Securities's ALBO Position: Q4 2014 in Review

First New York Securities sold out of Albireo Pharma Inc (ALBO) in Q4 2014, closing a stake of 9,041 shares — an estimated $453K sold.

First New York Securities first reported a position in ALBO in Q3 2013 and held it in 4 quarters. The position peaked at $1.64M in Q4 2013. 35 funds tracked by Wall St. Rank hold ALBO as of Q4 2014.

First New York Securities reported no remaining Albireo Pharma Inc position as of Q4 2014 after selling out during the quarter.
First New York Securities sold 9,041 Albireo Pharma Inc shares in Q4 2014, an estimated $453K.
First New York Securities first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 4 quarters.
First New York Securities's Albireo Pharma Inc position peaked at $1.64M in Q4 2013.
35 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2014.

Based on First New York Securities's 13F filing for Q4 2014, filed 9 Jan 2015.